A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma (2026) Haydu JE, Redd RA, Lei MM, Hochberg EP, Barnes JA, Armand P, Soumerai JD, et al. Journal article The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD (2025) Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, et al. Journal article Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC (2025) Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz MA, Asada N, Ayuk F, et al. Journal article Long-term outcomes of patients with refractory cytopenia of childhood under observation only (2025) Drexler B, Schwarz-Furlan S, Baumann I, Rudelius M, Nöllke P, Lebrecht D, Ramamoorthy S, et al. Journal article Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025) Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, et al. Journal article Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia (2025) Ruhnke L, Bill M, Zukunft S, Eckardt JN, Schäfer S, Stasik S, Hanoun M, et al. Journal article Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD (2025) Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, et al. Journal article Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT (2024) Nagler A, Labopin M, Tischer J, Raiola AM, Kunadt D, Vydra J, Blaise D, et al. Journal article HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products (2024) Winterhalter PM, Warmuth L, Hilgendorf P, Schütz JM, Dötsch S, Tonn T, Cicin-Sain L, et al. Journal article